Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
InnoSIGN logo — Comprehensive Pathway Analysis

InnoSIGN

Comprehensive Pathway Analysis

Founded 2022 The Netherlands The Netherlands 5 employees Series A Total: $8.00M Biotechnology, Life Sciences

General Information

Company Name InnoSIGN
Founded Year 2022
Location The Netherlands The Netherlands +2
Employees 5
Industries Biotechnology, Life Sciences
Funding Stage Series A
Social

Get notified when InnoSIGN moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About InnoSIGN

InnoSIGN, founded in 2022 and headquartered in The Netherlands, is a dynamic player in the Biotechnology and Life Sciences industries. The company’s tagline, "Comprehensive Pathway Analysis," encapsulates its mission to revolutionize disease understanding.

InnoSIGN’s distinguishing feature is its biology-first approach to comprehending signaling pathways through its proprietary platform. This innovative solution quantifies the activity of over 10 critical disease-driving pathways using structured machine learning algorithms honed over a decade of research at Philips. The company’s platform is designed to provide partners with deeper insights, facilitating accelerated discoveries and innovations.

In March 2022, InnoSIGN secured a substantial $8.00M Series A investment from prominent investors including Casdin Capital, Life Science Angels, Thuja Capital, and BOM - Brabant Regional Development Agency. This financial backing signifies strong investor confidence in InnoSIGN's potential to impact the biotech sector significantly.

Taxonomy: biotech, precision medicine, pathway analysis, mRNA profiling, signaling pathways, disease driver events, machine learning in biotech, diagnostics, oncology, molecular diagnostics, drug discovery, genomics, qPCR tests, structured ML algorithms, service testing facility

Services & Products

Comprehensive Disease Analysis
Data Interpretation from Omics
Actionable Insights for Drug Development

Target Customers

Pharmaceutical Companies Biotech Firms Research Institutions Healthcare Professionals

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor Investor
•••• •••• 		01 Mar 2022

InnoSIGN Alternatives & Competitors

View All Alternatives
InnoSIGN vs
Macomics
Macomics United Kingdom

Macrophage Biology Revealed:Developing breakthrough approaches to macrophage activity to change the...

Series A
24 employees
Biotechnology, Health and Wellness
InnoSIGN vs
Celldom, Inc.
Celldom, Inc. United States

Find and study cells that make diseases incurable

Seed
8 employees
Biotechnology, Health Care
InnoSIGN vs
Silverback Therapeutics
Silverback Therapeutics

We are a clinical-stage biopharmaceutical company leveraging our proprietary ImmunoTAC technology pl...

Series C
7 employees
Biopharma, Biotechnology
View all alternatives

FAQ About InnoSIGN

Comprehensive Pathway Analysis
InnoSIGN was founded in 2022.
InnoSIGN is headquartered in The Netherlands.
InnoSIGN operates in the following industries: Biotechnology, Life Sciences.
InnoSIGN has approximately 5 employees.
InnoSIGN has completed 1 funding round, raising a total of $8.00M. The latest funding stage is Series A.
InnoSIGN offers: Comprehensive Disease Analysis, Data Interpretation from Omics, Actionable Insights for Drug Development.
Top alternatives and competitors to InnoSIGN include Macomics, Celldom, Inc., Silverback Therapeutics, Lenus Health, Anima Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
InnoSIGN and Macomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors InnoSIGN and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy